购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空
筛选
已筛选:全部清除
TargetMol | Tags 通过 靶点 筛选
  • Cholecystokinin Receptor
    (2)
  • Others
    (2)
TargetMol | Tags 通过 货期 筛选
  • 现货
    (1)
  • 5日内发货
    (1)
  • 35日内发货
    (4)
抑制剂&激动剂
细分筛选
搜索结果
TargetMol产品目录中 "z 360"的结果
筛选
搜索结果
TargetMol产品目录中 "

z 360

"的结果
  • 抑制剂&激动剂
    6
    TargetMol | Inhibitors_Agonists
  • 多肽产品
    2
    TargetMol | Peptide_Products
  • 染料试剂
    1
    TargetMol | Dye_Reagents
  • Nastorazepide
    Z-360
    TQ0062209219-38-5
    Nastorazepide 是一种选择性的、口服有效的1,5-苯并二氮杂环衍生物胃泌素 胆囊收缩素2(CCK-2)受体拮抗剂,具有抗肿瘤的潜能。
    • ¥ 415
    In stock
    规格
    数量
  • Nastorazepide hemicalcium
    Z-360 hemicalcium
    T201854343326-69-2
    Nastorazepide (Z-360) hemicalcium 作为一种1,5-苯二氮卓衍生物,是选择性的口服胃泌素 胆囊收缩素 2 (CCK-2) 受体拮抗剂,展现了潜在的抗肿瘤效果。
    • 待询
    规格
    数量
  • Z-VAD-AMC (acetate)
    T36334
    Z-VAD-AMC is a fluorogenic substrate for caspase-1. Upon enzymatic cleavage by caspase-1, 7-amino-4-methylcoumarin (AMC) is released and its fluorescence can be used to quantify caspase-1 activity. AMC displays excitation/emission maxima of 340-360/440-460 nm, respectively.
    • 待估
    35日内发货
    规格
    数量
  • Z-LLE-AMC
    T37417348086-66-8
    Z-LLE-AMC is a fluorogenic substrate for the caspase-like post-glutamate peptide hydrolase of the 26S proteasome or 20S proteolytic core. Caspase-like activity can be quantified by fluorescent detection of free AMC (also known as 7-amino-4-methylcoumarin), which is excited at 340-360 nm and emits at 440-460 nm. Z-LLE-AMC is typically used in cell lysates after experimental treatment.
    • 待估
    35日内发货
    规格
    数量
  • Z-LLL-AMC
    T37418152015-61-7
    Z-LLL-AMC is a fluorogenic substrate for the chymotrypsin-like activity of the 26S proteasome or 20S proteolytic core. Chymotrypsin-like activity can be quantified by fluorescent detection of free AMC (also known as 7-amino-4-methylcoumarin), which is excited at 340-360 nm and emits at 440-460 nm. Z-LLL-AMC is typically used in cell lysates after experimental treatment.
    • 待估
    35日内发货
    规格
    数量
  • D-DOPA
    T376055796-17-8
    D-DOPA is an enantiomer of the dopamine precursor L-DOPA . It can be converted to L-DOPAviasequential oxidation and transamination, which are mediated by D-amino acid oxidase (DAAO) and DOPA transaminase, respectively, in rat kidney homogenates.1It reduces the number of dopaminergic neurons in primary rat embryonic mesencephalic cultures in a concentration-dependent manner.2Intraventricular administration of D-DOPA (200 μg/animal) increases striatal dopamine levels in rats.3D-DOPA (20 mg/kg, i.p.) induces contralateral turns in a rat model of Parkinson's disease induced by 6-OHDA .4 1.Wu, M., Zhou, X.-J., Konno, R., et al.D-dopa is unidirectionally converted to L-dopa by D-amino acid oxidase, followed by dopa transaminaseClin. Exp. Pharmacol. Physiol.33(11)1042-1046(2006) 2.Ling, Z.-D., Pieri, S.C., and Carvey, P.M.Comparison of the neurotoxicity of dihydroxyphenylalanine stereoisomers in cultured dopamine neuronsClin. Neuropharmacol.19(4)360-365(1996) 3.Karoum, F., Freed, W.J., Chuang, L.-W., et al.D-dopa and L-dopa similarly elevate brain dopamine and produce turning behavior in ratsBrain Res.440(1)190-194(1988) 4.Moses, J., Siddiqui, A., and Silverman, P.B.Sodium benzoate differentially blocks circling induced by D-and L-dopa in the hemi-parkinsonian ratNeurosci. Lett.218(3)145-148(1996)
    • 待估
    35日内发货
    规格
    数量